Amphastar Pharmaceuticals, Inc. (AMPH) stock
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3013% below fair value
$29.10−0.07 (-0.24%)
Close on Nov 17, 2026Market cap $1.24BP/E 17.1Yield –
Amphastar Pharmaceuticals operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Amphastar Pharmaceuticals's operating income for the twelve months ending Jun 30, 2026 was $114.29M, down 37.1% year over year. For fiscal 2025 it was $140.40M, down 31.7% from the year before. The highest annual figure on record is $205.42M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $140.40M | -31.7% |
| FY2024 | Dec 31, 2024 | $205.42M | +4.3% |
| FY2023 | Dec 31, 2023 | $196.99M | +83.2% |
| FY2022 | Dec 31, 2022 | $107.50M | +53.8% |
| FY2021 | Dec 31, 2021 | $69.89M | +538.0% |
| FY2020 | Dec 31, 2020 | $10.95M | – |
| FY2019 | Dec 31, 2019 | -$39.00K | – |
| FY2018 | Dec 31, 2018 | -$8.62M | – |
| FY2017 | Dec 31, 2017 | -$1.27M | -108.3% |
| FY2016 | Dec 31, 2016 | $15.38M | – |
| FY2015 | Dec 31, 2015 | -$6.90M | – |
| FY2014 | Dec 31, 2014 | -$17.98M | -202.8% |
| FY2013 | Dec 31, 2013 | $17.49M | -31.1% |
| FY2012 | Dec 31, 2012 | $25.40M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $39.73M | -5.8% |
| Q1 FY2026 | Mar 31, 2026 | $13.63M | -63.5% |
| Q4 FY2025 | Dec 31, 2025 | $35.61M | -21.1% |
| Q3 FY2025 | Sep 30, 2025 | $25.32M | -55.6% |
| Q2 FY2025 | Jun 30, 2025 | $42.18M | -23.6% |
| Q1 FY2025 | Mar 31, 2025 | $37.29M | -22.3% |
| Q4 FY2024 | Dec 31, 2024 | $45.14M | -16.4% |
| Q3 FY2024 | Sep 30, 2024 | $57.05M | -21.5% |
| Q2 FY2024 | Jun 30, 2024 | $55.22M | +49.7% |
| Q1 FY2024 | Mar 31, 2024 | $48.01M | +43.6% |
| Q4 FY2023 | Dec 31, 2023 | $53.98M | +42.7% |
| Q3 FY2023 | Sep 30, 2023 | $72.68M | +212.9% |
| Q2 FY2023 | Jun 30, 2023 | $36.90M | +48.6% |
| Q1 FY2023 | Mar 31, 2023 | $33.43M | +54.7% |
| Q4 FY2022 | Dec 31, 2022 | $37.83M | +56.0% |
| Q3 FY2022 | Sep 30, 2022 | $23.23M | -6.2% |
| Q2 FY2022 | Jun 30, 2022 | $24.82M | +135.1% |
| Q1 FY2022 | Mar 31, 2022 | $21.61M | +109.7% |
| Q4 FY2021 | Dec 31, 2021 | $24.25M | +742.4% |
| Q3 FY2021 | Sep 30, 2021 | $24.77M | +604.3% |
| Q2 FY2021 | Jun 30, 2021 | $10.56M | – |
| Q1 FY2021 | Mar 31, 2021 | $10.31M | +37.8% |
| Q4 FY2020 | Dec 31, 2020 | $2.88M | – |
| Q3 FY2020 | Sep 30, 2020 | $3.52M | +46.3% |
| Q2 FY2020 | Jun 30, 2020 | -$2.92M | -400.3% |
| Q1 FY2020 | Mar 31, 2020 | $7.48M | – |
| Q4 FY2019 | Dec 31, 2019 | -$244.00K | -115.8% |
| Q3 FY2019 | Sep 30, 2019 | $2.40M | -5.7% |
| Q2 FY2019 | Jun 30, 2019 | $973.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.17M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.55M | – |
| Q3 FY2018 | Sep 30, 2018 | $2.55M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.94M | -234.6% |
| Q1 FY2018 | Mar 31, 2018 | -$9.78M | -796.4% |
| Q4 FY2017 | Dec 31, 2017 | -$1.75M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.94M | -150.8% |
| Q2 FY2017 | Jun 30, 2017 | $2.19M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.40M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.83M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.80M | – |
See a number that looks wrong?